It is hoped the prospective sale provides a haven for wildlife in an urban area.
When performing ear reflexology, do you ever find yourself wondering, "Which points should I choose today?"You choose points ...
InvestorsHub on MSN
BioAffinity Technologies receives Japanese patent allowance for CyPath Lung AI diagnostic test
The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive ...
The number of ordering physicians increased by 89% in Q3 2026 compared to Q3 2025. Physicians who ordered CyPath Lung through Q3 2025 continued to expand utilization of the test, with sales volume ...
The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
Some facial changes are viewed differently in traditional Chinese medicine (TCM), and a few can signal the need for prompt care.
Bipartisan legislation that would establish a statewide lung cancer screening awareness and referral program for first ...
Smoking cessation in lung cancer screening improved significantly when financial incentives were added to usual care and free ...
AstraZeneca PLC (US) (NYSE:AZN) is on the cusp of unlocking a new growth engine in lung cancer treatment. On September 29, ...
A Chinese research team used CT radiomics and machine learning to distinguish harmless ground-glass lung nodules from ...
Enrollment completed in Part C of THIO-101 Phase 2 study; 65% of 2026 enrollment target reached in pivotal THIO-104 Phase 3 studyCHICAGO, Oct.
Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results